Reimagining vaccine delivery with oral tablet immunization

“we built an adjuvant system where a double‑stranded RNA hairpin is co‑expressed along with the protein of interest to generate a strong immune response.”

Charlotte Barker, Editor, Vaccine Insights, speaks with Sean Tucker, Founder and Chief Scientific Officer, Vaxart, about the scientific and translational journey behind the company's oral tablet vaccines and the use of controlled human infection models to refine immune correlates.

Please enter your email to access content Read now